This inventor holds 2 USPTO granted patents. Top assignee: Harvard College. Active years: 1983-1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1983-1986
Title: Lydia J Villa-Komaroff: A Pioneer in Recombinant DNA Technology
Introduction
Lydia J Villa-Komaroff is a prominent inventor known for her groundbreaking work in recombinant DNA technology. Based in Boston, MA, she has made significant contributions to the field of molecular biology. With a total of 2 patents, her innovations have had a lasting impact on biotechnology and medicine.
Latest Patents
Villa-Komaroff's latest patents focus on the synthesis of proteins using recombinant DNA techniques. One of her notable inventions involves a plasmid or phage gene for a periplasmic or extracellular bacterial protein. In this process, a double-stranded DNA sequence coding for a selected protein, such as insulin, is inserted into the cleaved gene. This technique allows for the transformation of bacteria, leading to the collection of the excreted selected protein. Her work in protein synthesis has paved the way for advancements in therapeutic protein production.
Career Highlights
Throughout her career, Villa-Komaroff has been associated with Harvard College, where she has contributed to various research initiatives. Her expertise in molecular biology and genetics has positioned her as a leader in her field. She has been instrumental in advancing our understanding of genetic engineering and its applications in medicine.
Collaborations
Villa-Komaroff has collaborated with esteemed colleagues, including Walter Gilbert and Stephanie A Broome. These partnerships have fostered innovation and have led to significant advancements in the field of biotechnology.
Conclusion
Lydia J Villa-Komaroff's contributions to recombinant DNA technology and protein synthesis have established her as a key figure in the scientific community. Her work continues to influence the development of new therapies and biotechnological applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
